TY - JOUR
T1 - The reorganization of functional architecture in the early-stages of Parkinson's disease
AU - Tuovinen, Noora
AU - Seppi, Klaus
AU - de Pasquale, Francesco
AU - Müller, Christoph
AU - Nocker, Michael
AU - Schocke, Michael
AU - Gizewski, Elke R.
AU - Kremser, Christian
AU - Wenning, Gregor K.
AU - Poewe, Werner
AU - Djamshidian, Atbin
AU - Scherfler, Christoph
AU - Seki, Morinobu
N1 - Funding Information:
N.T. reports grants from Austrian Science Fund (FWF: Der Wissenschaftsfonds, project number: KLI82-B00), FP7 post-grant Open Access publishing funds, personal funding from the Instrumentarium Science Foundation (Finland). K.S. reports grants from Medical University Innsbruck, grants from Oesterreichische Nationalbank Nationalbank (Austrian Central Bank, Anniversary Fund; project no.: 14174), grants from Austrian Science Fund (FWF: Der Wissenschaftsfonds; project no.: KLI82-B00), grants from the Michael J. Fox Foundation (project: PPMI study), personal fees from International Parkinson and the Movement Disorder Society, personal fees from Teva, personal fees from UCB, personal fees from Lundbeck, personal fees from AOP Orphan, personal fees from Roche and personal fees from Abbvie outside the submitted work. C.M. reports none. M.N. reports none. M.Sc. reports none. E.R.G. reports honoraria from Bayer and Bracco for 2 presentations. C.K. reports none. G.K.W. reports consulting and/or honoraria from Astra, Abbvie, and Lundbeck as well as grant support from Austrian Science Foundation, E-Rare 3, EU 7th FP, US MSA Coalition. He receives royalties from Cambridge University Press and Springer. W.P. reports personal fees from AbbVie, Allergan, AstraZeneca, BIAL, Boehringer-Ingelheim, Boston Scientific, Cynapsus, GlaxoSmithKline, Grünenthal, Ipsen, Lundbeck, Medtronic, MSD, Merck-Serono, Merz Pharmaceuticals, Neuroderm, Novartis, Orion Pharma, Teva, UCB and Zambon (consultancy and lecture fees in relation to clinical drug development programmes for PD) outside the submitted work. A.D. reports travelling grants from AOP Orphan Pharmaceuticals AG and Medtronic. C.S. reports none. M.Se. reports grants from the Uehara Memorial Foundation and Grants for International Activities in Life Sciences and Medicine and Keio University Medical School Fund.
Funding Information:
This study was supported by grants from Austrian Science Fund (FWF: Der Wissenschaftsfonds, project number: KLI82-B00 ) and Instrumentarium Science Foundation , Finland (to N. Tuovinen).
Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/5
Y1 - 2018/5
N2 - Introduction: The study aim was to identify longitudinal abnormalities of functional connectivity and its relation with motor disability in early to moderately advanced stages of Parkinson's disease patients. Methods: 3.0T structural and resting-state functional MRI was performed in healthy subjects (n = 16) and Parkinson's disease patients (n = 16) with mean disease duration of 2.2 ± 1.2 years at baseline with a clinical follow-up of 1.5 ± 0.3 years. Resting-state fMRI analysis included region-to-region connectivity in correlation with UPDRS-III scores and computation of Global Efficiency and Degree Centrality. Results: At baseline, patients' connectivity increased between the cerebellum and somatomotor network, and decreased between motor regions (Rolandic operculum, precentral gyrus, supplementary motor area, postcentral gyrus) and cingulate connectivity. At 1.5 years follow-up, connectivity remained altered in the same regions identified at baseline. The cerebellum showed additional hyperconnectivity within itself and to the caudate nucleus, thalamus and amygdala compared to controls. These differences correlated with UPDRS-III scores. Seed-based connectivity revealed increased involvement of the default mode network with precentral gyrus in patients at follow-up investigation. Conclusion: Resting-state fMRI identified marked disturbances of the overall architecture of connectivity in Parkinson's disease. The noted alterations in cortical motor areas were associated with cerebellar hyperconnectivity in early to moderately advanced stages of Parkinson's disease suggesting ongoing attempts of recovery and compensatory mechanism for affected functions. The potential to identify connectivity alterations in regions related to both motor and attentional functions requires further evaluation as an objective marker to monitor disease progression, and medical, as well as surgical interventions.
AB - Introduction: The study aim was to identify longitudinal abnormalities of functional connectivity and its relation with motor disability in early to moderately advanced stages of Parkinson's disease patients. Methods: 3.0T structural and resting-state functional MRI was performed in healthy subjects (n = 16) and Parkinson's disease patients (n = 16) with mean disease duration of 2.2 ± 1.2 years at baseline with a clinical follow-up of 1.5 ± 0.3 years. Resting-state fMRI analysis included region-to-region connectivity in correlation with UPDRS-III scores and computation of Global Efficiency and Degree Centrality. Results: At baseline, patients' connectivity increased between the cerebellum and somatomotor network, and decreased between motor regions (Rolandic operculum, precentral gyrus, supplementary motor area, postcentral gyrus) and cingulate connectivity. At 1.5 years follow-up, connectivity remained altered in the same regions identified at baseline. The cerebellum showed additional hyperconnectivity within itself and to the caudate nucleus, thalamus and amygdala compared to controls. These differences correlated with UPDRS-III scores. Seed-based connectivity revealed increased involvement of the default mode network with precentral gyrus in patients at follow-up investigation. Conclusion: Resting-state fMRI identified marked disturbances of the overall architecture of connectivity in Parkinson's disease. The noted alterations in cortical motor areas were associated with cerebellar hyperconnectivity in early to moderately advanced stages of Parkinson's disease suggesting ongoing attempts of recovery and compensatory mechanism for affected functions. The potential to identify connectivity alterations in regions related to both motor and attentional functions requires further evaluation as an objective marker to monitor disease progression, and medical, as well as surgical interventions.
KW - Functional brain connectivity
KW - Functional magnetic resonance imaging (fMRI)
KW - Longitudinal
KW - Parkinson's disease
UR - http://www.scopus.com/inward/record.url?scp=85041952544&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041952544&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2018.02.013
DO - 10.1016/j.parkreldis.2018.02.013
M3 - Article
C2 - 29449186
AN - SCOPUS:85041952544
SN - 1353-8020
VL - 50
SP - 61
EP - 68
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
ER -